Contact This Organization

Wave Therapeutics

Wave Therapeutics has developed a new, patent pending technology designed to improve comfort while reducing the risks of pressure injuries (bedsores) and blood clots. Our devices combine two clinically validated therapeutic processes to eliminate pressure "hot spots" and assist with venous blood return. In addition, our smart devices utilize arrays of sensors to provide patients and clinicians with real-time data to inform better treatment decisions. Our technology is affordable, works better than anything else on the market, and has medical, consumer, and even military application with market sizes of hundreds of billions of dollars. We’re a woman-owned, minority business and we’d love to tell you more about our story.
Mission/Vision
To end the problem of bedsores with our smart cushioning technology
Type of Organization
Startup - Newly established businesses, investable
Size of Organization
0-10
Organization Mailing Address

PO Box 1842
Nashville, IN 47448
United States

Affordable and Effective Smart Cushioning Technology
Our devices combine two clinically validated therapeutic processes to eliminate pressure "hot spots" and assist with venous blood return. In addition, our smart devices utilize arrays of sensors to provide patients and clinicians with real-time data to inform better treatment decisions.
Category of Innovation
Life Sciences - Life science solutions are those solutions that are delivered as a drug or device that typically require federal approval
Intended End User
Patient - Individuals who receive health care
Provider - Individuals or organizations responsible for providing care to patients (e.g. doctors, nurses, hospital/clinic administrators, etc.)
Impactful Innovation Stage (Click Here for Details)
Solution
Problem (i.e. barrier, issue, complication, etc.) being solved for the end user
pressure injuries, pressure ulcers, bedsores, poor tissue perfusion, DVT's, deep vein thrombosis, embolism, blood clots
Idea/solution to the problem, if applicable
Combining alternating pressure with sequential compression. Incorporating sensor arrays, communications, processing power, and data analytics
Level of adoption (i.e. list of customers/users, testimonials, etc.), if applicable
Pre-market
Impact (i.e. measurable outcomes), if applicable
We look to help save the lives of the 60,000 Americans who die each year due to pressure injuries.
Funding Stage
Seed
List of Funding Sources (if applicable)
Founders Equity: $250,000
Pre-Seed: $500,000
Currently Raising $2M Seed